4//SEC Filing
Levi Ofir 4
Accession 0001104659-21-068837
CIK 0001824293other
Filed
May 17, 8:00 PM ET
Accepted
May 18, 4:08 PM ET
Size
7.8 KB
Accession
0001104659-21-068837
Insider Transaction Report
Form 4
Levi Ofir
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-05-14+30,000→ 30,000 totalExercise: $3.66Exp: 2031-05-14→ Common Stock (30,000 underlying) - Award
Stock Option (Right to Buy)
2021-05-14+15,000→ 15,000 totalExercise: $3.66Exp: 2031-05-14→ Common Stock (15,000 underlying)
Footnotes (2)
- [F1]The stock option vests as to 50% of the underlying shares of common stock on June 30, 2021, then in two equal installments on September 30, 2021 and December 31, 2021, such that the stock option fully vests on December 31, 2021.
- [F2]The stock option vests in 24 equal monthly installments such that the stock option is fully vested on the second annual anniversary of the date of grant.
Documents
Issuer
Vallon Pharmaceuticals, Inc.
CIK 0001824293
Entity typeother
Related Parties
1- filerCIK 0001843598
Filing Metadata
- Form type
- 4
- Filed
- May 17, 8:00 PM ET
- Accepted
- May 18, 4:08 PM ET
- Size
- 7.8 KB